Registration

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.

LobbyistCovered position, as disclosed
MICHAEL J EGING New Vice President, Government Affairs

Government Issues GOV

Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.

LobbyistCovered position, as disclosed
MICHAEL J EGING New Vice President, Government Affairs

Health Issues HCR

Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.

LobbyistCovered position, as disclosed
MICHAEL J EGING New Vice President, Government Affairs

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
H. LUNDBECK A/S Denmark Denmark 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.